COPD trials in Malaysia

In Malaysia 6 Also abroad 559

6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo
Where
George Town, Kuala Lumpur, Kuala Selangor, Kuching, Malacca
Age
30 years to 80 years
People
1,400 worldwide
Run by
AstraZeneca
See details and how to joinNCT07069829
Phase 3Not yet taking people in Malaysia
The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease
Where
Kajang, Kelantan, Kuala Lumpur
Age
40 years and over
People
1,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07907991 · EU 2026-527805-39-00
Phase 3Taking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Where
George Town, Kajang, Kota Bharu, Kuala Lumpur, Kuala Terengganu, Miri, Sibu
Age
40 years to 80 years
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00
Phase 3Taking people
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Where
Alor Star, Kajang, Kuala Lumpur, Kuala Pilah, Sandakan, Sarawak Miri, Seremban, Sibu
Age
40 years to 80 years
People
5,250 worldwide
Run by
AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00
Phase 3Taking people
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Where
Alor Star, Kajang, Kota Kinabalu, Kuala Lumpur, Kuala Terengganu, Kuantan, Kuching
Age
40 years to 80 years
People
990 worldwide
Run by
AstraZeneca
See details and how to joinNCT06883305 · EU 2024-517458-90-00
No phaseTaking people
Efficacy & Safety of Dry Powder Ivy Extract (Syrup Prospan) Versus NAC Among COPD Patients
Where
Cheras
Age
40 years and over
People
100
Run by
National University of Malaysia
See details and how to joinNCT06377410